Evaluation of the Liver Multiscan MRI for NASH (CATE-NASH)
Aim: To evaluate the Liver Multiscan as an alternative to liver biopsy in NAFLD and NASH
HIV-NASH AIM 1 Trial
Aim: To determine the prevalence of NAFLD or NASH in persons living with HIV
Tissue Repository for the Study of NAFLD
Aim: To understand the risk factors for progressive liver disease and cardiometabolic complications of NAFLD, and to identify non-invasive biomarkers for NASH and fibrosis
Intra-Hepatic Immune Signature in NAFLD
Aim: To identify immune cell subsets with pathogenic and/or protective functions in relation to inflammation and fibrosis in the liver in the context of NASH
Fine Needle Aspiration Biopsy (FNAB)-NASH
Aim: To study single cell transcriptome profile of liver fine needle aspirations (FNAB) derived macrophages
Intermittent Fasting for the Treatment of NAFLD
Aim: A 6 week study of intermittent fasting for the treatment of NAFLD
Aldafermin for the Treatment of NASH Cirrhosis
Aim: To evaluate the efficacy of GHRH for the treatment of NASH, fibrosis and cardiovascular risk